TruthArchive.ai - Related Video Feed

"The mRNA vaccines, you know, from COVID don't work against upper respiratory infections." "There are two problems with them." "One is they target a single protein, which drives what what's called an antigenic shift." "If it drives the virus to mutate, and it actually can prolong the pandemic." "We saw that during COVID, people took shots, mRNA shots for the original COVID variant and immediately, mutated into the Omicron virus to which the vaccine was ineffective, and that's what it does." "And the other issue is, that it the way that distributes in the body, the way that it migrates in the body, there's no control over and no predictability." "So it goes to every organ." "It turns your body into a an antigen factory where you're manufacturing antigens, and different people need different loads of antigens." "And we've seen now these epidemics of myocarditis and pericarditis, particularly in kids."

Robert F. Kennedy Jr. states that HHS, via BARDA, is canceling 22 mRNA vaccine development investments, mostly for flu and COVID. He claims mRNA vaccines don't perform well against viruses infecting the upper respiratory tract because mRNA only codes for a small part of viral proteins, and one mutation can make the vaccine ineffective. Kennedy alleges this drives antigenic shift, where vaccines encourage new mutations, prolonging pandemics as viruses mutate to escape the vaccine's protection. He asserts that HHS, after reviewing science and consulting experts at NIH and FDA, determined mRNA technology poses more risk than benefits for respiratory viruses. According to Kennedy, BARDA is terminating contracts totaling just under $500,000,000 and prioritizing safer, broader vaccine strategies like whole virus vaccines. He clarifies that HHS supports safe, effective vaccines but is moving beyond mRNA's limitations for respiratory viruses.

Secretary Kennedy has achieved a major victory, effectively silencing many critics. While not a complete ban on mRNA, the government, through BARDA, will cease investing in these technologies. Additionally, their global health investment corporation partner is advised to halt all equity investments in modified RNA technologies. The expectation is that without government funding, these technologies will diminish. This development is considered a bombshell with worldwide repercussions.

The speaker believes that halting mRNA vaccine research and development at BARDA is a tragic, non-science-based mistake. They state that mRNA vaccines saved lives, citing estimates that in 2021, unvaccinated individuals were 12 times more likely to be hospitalized and die, and in 2022, six times more likely. The speaker, a member of the FDA vaccine advisory committee, notes initial concerns about potential serious side effects when the vaccine was rolled out to millions, but these did not materialize. While the vaccine can cause rare myocarditis, it is transient and self-resolving, unlike myocarditis caused by the virus itself, which can lead to hospitalization and death. The speaker emphasizes the technology's potential beyond COVID-19, including applications for cancer and gene therapy.

mRNA vaccines code for a small part of viral proteins, usually a single antigen. A single mutation can make the vaccine ineffective. This drives antigenic shift, where the vaccine encourages new mutations, prolonging pandemics as the virus mutates to escape the vaccine's protection. Millions caught the Omicron variant despite vaccination because a single mutation can render mRNA vaccines ineffective. The same risk applies to the flu.

Robert F. Kennedy Jr., as HHS Secretary, states that BARDA is canceling 22 mRNA vaccine development investments, primarily for flu and COVID. He claims mRNA vaccines don't perform well against upper respiratory viruses because they only code for a small part of viral proteins, and a single mutation can make them ineffective. Kennedy alleges this drives antigenic shift, where vaccines encourage new mutations, potentially prolonging pandemics. He asserts that millions contracted Omicron despite vaccination, illustrating this risk. HHS, after consulting NIH and FDA experts, has determined mRNA technology poses more risk than benefit for respiratory viruses. The canceled contracts total just under $500 million. HHS will prioritize safer, broader vaccine strategies like whole virus vaccines and novel platforms that don't collapse when viruses mutate. Kennedy states HHS supports safe, effective vaccines but is moving beyond mRNA limitations for respiratory viruses.

US Health Secretary Robert F. Kennedy has reportedly blocked half a billion dollars in funding for respiratory disease vaccine research, canceling over 20 government contracts for mRNA jabs. Kennedy, described as a longtime vaccine skeptic, stated his department concluded the vaccines pose more risk than protection against respiratory illness. Jonathan Ball, Professor of Molecular Virology at the Liverpool School of Tropical Medicine, responded by calling the move an example of misinformation and anti-science. He stated that mRNA vaccines have been incredibly effective, helped bring the COVID pandemic under control, and offer great hope for other infectious diseases.

Over the past few weeks, BARDA reviewed 22 mRNA vaccine development investments and began canceling them. Here's the problem: mRNA only codes for a small part of the viral proteins, usually a single antigen. One mutation and the vaccine becomes ineffective. That's because a single mutation can make mRNA vaccines ineffective. After reviewing the science and consulting top experts at NIH and FDA, HHS has determined that mRNA technology poses more risk than benefits for these respiratory viruses. To replace the troubled mRNA programs, we're prioritizing the development of the safer, broader vaccine strategies like whole virus vaccines and novel platforms that don't collapse when viruses mutate. Let me be absolutely clear: HHS supports safe, effective vaccines for every American who wants them.

Speaker 0 argues that "Big pharma is just not gonna sit there and go, this is wonderful. Bobby Kennedy, who's an anti vax wingnut, just canceled the most promising technology out there." He cites BARDA actions—"cancellation, descoping of various contracts and solicitations relate to mRNA vaccine development activities"—and says "We reviewed the science, listened to the experts enacted." He calls the "buried lead" that "you have to show the receipts here," warning that "the companies out there that are publicly traded" will pursue "massive lawsuits" and that critics are "a bunch of vaccine wingnuts." He urges HHS/BARDA to present "what we looked at" and "the underlying science" to back their conclusions, which he says are "180 degrees from what people have been spoon fed by the most credentialed class in the country." Speaker 1 adds that "over 3,500 peer reviewed papers" show harms and can be found at react19.org; "continued science comes out showing the harms." We should have done this research before immunization. Pharma will come back "guns blazing." We must "unify" scientists and, in court, "make the case that this was a good decision." He calls the stance an "opening salvo" and predicts the battle "is gonna be massive."

The speaker is questioned about the Health Secretary pulling funding for mRNA vaccine research, claiming the risks outweigh the benefits, putting him at odds with the medical community. The speaker responds that Operation Warp Speed was considered incredible, regardless of political affiliation, citing its efficiency and distribution. While acknowledging that Warp Speed was "a long time ago," the speaker states that they are "on to other things" and are looking for answers to other sicknesses and diseases. They mention upcoming meetings to determine the next steps.

Secretary Kennedy has achieved a significant victory, effectively silencing many critics. While not a ban on mRNA, the government, through BARDA, will cease investing in these technologies. Additionally, their global health investment corporation partner is advised to halt all equity investments in modified RNA technologies. The expectation is that without funding, these technologies will diminish. This development is considered a bombshell with worldwide repercussions.

An Australian woman has chronicled the money trail showing universities receiving millions to create messenger RNA factories. Messenger RNA vaccines are not needed, will never be better than existing vaccines, and bring huge, unsorted adverse events. However, they are patented and allow for creating new vaccines yearly, like the latest RSV vaccine. The speaker hopes to see a proper assessment of its value. Pfizer's messenger RNA flu vaccine failed, which the speaker sees as a good thing because messenger RNA vaccines for flu are frightening.

"this is a massive win for Secretary Kennedy and basically a silencing of many of the critics." "It's not a ban on mRNA like many people would like to see." "However, it is the wind down of the government investing through BARDA in these technologies." "and their global health investment corporation partner is advised to stop all equity investments in modified RNA technologies." "So follow the money." "When the money isn't there, these are going to fizzle." "This is a bombshell." "The repercussions are going to be felt worldwide." "There will be backlash." "It's not for human use." "This de investment in these 22 projects, it's just the beginning."

Robert F. Kennedy Jr. states that HHS, via BARDA, is canceling 22 mRNA vaccine development investments, mostly for flu and COVID. He claims mRNA vaccines don't perform well against viruses infecting the upper respiratory tract because mRNA only codes for a small part of viral proteins, and one mutation can make the vaccine ineffective. Kennedy alleges this drives antigenic shift, where vaccines encourage mutations and prolong pandemics as viruses mutate to escape the vaccine's protection. HHS has determined that mRNA technology poses more risk than benefits for these respiratory viruses. The canceled contracts total just under $500,000,000. HHS is prioritizing safer, broader vaccine strategies like whole virus vaccines and novel platforms that don't collapse when viruses mutate. HHS supports safe, effective vaccines but is moving beyond the limitations of mRNA for respiratory viruses.

Robert F. Kennedy Jr.: Hi, it's Robert F. Kennedy Jr. here, your HHS secretary. At HHS, we have a division called the Biomedical Advanced Research and Development Authority, or BARDA. BARDA drives some of our most advanced scientific research. It funds developments of vaccines, drugs, diagnostics, and other tools to fight emerging diseases and national health threats. Over the past few weeks, BARDA reviewed 22 mRNA vaccine development investments and began canceling them. Let me explain why. Most of these shots are for flu or COVID, but as the pandemic showed us, mRNA vaccines don't perform well against viruses that infect the upper respiratory tract. Here's the problem: mRNA only codes for a small part of the viral proteins, usually a single antigen. One mutation and the vaccine becomes ineffective. This dynamic drives a phenomena called antigenic shift, meaning that the vaccine paradoxically encourages new mutations and can actually prolong pandemics as the virus constantly mutates to escape the protective effects of the vaccine. Millions of people, maybe even you or someone you know, caught the omicron variant despite being vaccinated. That's because a single mutation can make mRNA vaccines ineffective. The same risk applies to flu. After reviewing the science and consulting top experts at NIH and FDA, HHS has determined that mRNA technology poses more risk than benefits for these respiratory viruses. That's why after extensive review, BARDA has begun the process of terminating these 22 contracts totaling just under $500,000,000 To replace the troubled mRNA programs, we're prioritizing the development of the safer, broader vaccine strategies, like whole virus vaccines and novel platforms that don't collapse when viruses mutate. Let me be absolutely clear: HHS supports safe, effective vaccines for every American who wants them. That's why we're moving beyond the limitations of mRNA for respiratory viruses and investing in better solutions. Thank you. Produced by the U. S. Department of Health and Human Services.

Robert F. Kennedy Jr. states that HHS, via BARDA, is canceling 22 mRNA vaccine development investments, mostly for flu and COVID, because mRNA vaccines don't perform well against upper respiratory viruses. mRNA only codes for a small part of viral proteins, and one mutation can make the vaccine ineffective, driving antigenic shift, which encourages new mutations and prolongs pandemics. Millions caught Omicron despite being vaccinated, demonstrating this. HHS determined mRNA technology poses more risk than benefit for respiratory viruses after consulting experts at NIH and FDA. BARDA is terminating contracts totaling just under $500 million. HHS is prioritizing safer, broader vaccine strategies like whole virus vaccines and novel platforms that don't collapse when viruses mutate. HHS supports safe, effective vaccines but is moving beyond the limitations of mRNA for respiratory viruses.

- The mRNA vaccines, you know, from COVID don't work against upper respiratory infections. - There are two problems with them. - One is they target a single protein, which drives what what's called an antigenic shift. - If it drives the virus to mutate, and it actually can prolong the pandemic. - And we saw that during COVID, people took shots, mRNA shots for the original COVID variant and immediately, mutated into the Omicron virus to which the vaccine was ineffective, and that's what it does. - And the other issue is, that it the way that distributes in the body, the way that it migrates in the body, there's no control over and no predictability. - So it goes to every organ.

The US Health Department intends to cancel contracts and cut funding for some vaccine development projects, including those targeting COVID-19. Health Secretary Robert F. Kennedy Jr. announced that $500 million in funding would be halted for 22 projects, many led by major drug makers like Pfizer and Moderna. These projects use mRNA technology. While mRNA vaccines are credited with slowing the 2020 coronavirus pandemic, Kennedy stated he wants the department to invest in "better solutions," but did not elaborate on what those solutions would be. The Department of Health and Human Services is pulling the funding and Kennedy is calling on the department to move away from mRNA vaccines.

The US Health Department intends to cancel contracts and cut funding for some vaccine development projects, including those targeting COVID-19. Health Secretary Robert F. Kennedy Jr. announced the halt of $500 million in funding for 22 projects, many led by major drug makers like Pfizer and Moderna. These projects utilize mRNA technology. While mRNA vaccines are credited with slowing the 2020 coronavirus pandemic, Kennedy stated he wants the department to invest in "better solutions," though he did not specify what those solutions would be.

RFK junior cancels 500 million mRNA research HHS to prioritize safer vaccines and study vaccine alternatives. They're studying everything. 22 mRNA vaccines development contracts canceled. Boom. 22, baby. California hospital concealed evidence linking catastrophic surge and still bursts in COVID vaccine lawsuit alleges held in New England Medical Journal came out four years ago. Eighty three percent increase in miscarriages in first two trimesters, twenty five percent twenty six percent increase in third trimester. We already know all this. It's incredible what they did to us. Produced by the US Department of Health. And, again, folks, these aren't vaccines. They changed the definition five years ago and before that, ten years ago. To anything they inject in your body, they just call a vaccine. But they're trying to strip the liability protection from the vaccine makers. It's all happening.

US Health Secretary Robert F. Kennedy has blocked $500 million in funding for respiratory disease vaccine research, canceling over 20 government contracts for mRNA jabs. Kennedy, a long-time vaccine skeptic, stated his department concluded the vaccines pose more risk than protection against respiratory illness. Professor Jonathan Ball, a Molecular Virology expert, responded by calling the move an example of misinformation and anti-science. He stated that mRNA vaccines have been incredibly effective, helped bring the COVID pandemic under control, and offer great hope for other infectious diseases.

Robert F. Kennedy Jr., as HHS Secretary, announces the cancellation of 22 BARDA mRNA vaccine development investments, primarily for flu and COVID. HHS determined mRNA vaccines pose more risk than benefit for respiratory viruses because they only code for a small part of viral proteins, and a single mutation can render them ineffective. This can drive antigenic shift, prolonging pandemics as viruses mutate to escape the vaccine's effects. Millions contracted Omicron despite vaccination, illustrating this risk. HHS will prioritize safer, broader vaccine strategies like whole virus vaccines and novel platforms that don't collapse when viruses mutate. The 22 contracts totaled just under $500,000,000. HHS supports safe, effective vaccines and is moving beyond mRNA limitations for respiratory viruses.

MRNA vaccines were hailed as medical breakthroughs in the fight against COVID. Now the US Department of Health and Human Services is slashing a half billion dollars in government funding from mRNA vaccine development. The current vaccines are not infection blocking. When new variants come up, you lose protection, and they have very short duration. There was never a vaccine made with mRNA. Lipid nanoparticles go everywhere in the body, to the brain, to the bone marrow, to the liver, to the spleen, most importantly to the reproductive organs. I regret it every single day that I walked into my local pharmacy to get that shot in my arm. The spike protein directly causes blood clotting and is found in the middle of large blood clots. This vaccine, the mRNA vaccine, has probably saved about three million lives.

- "After reviewing the science and consulting top experts at NIH and FDA, HHS has determined that mRNA technology poses more risk than benefits for these respiratory viruses." - "BARDA has begun the process of terminating these 22 contracts totaling just under $500,000,000 To replace the troubled mRNA programs, we're prioritizing the development of safer, broader vaccine strategies, like whole virus vaccines and novel platforms that don't collapse when viruses mutate." - "I'm still waiting for Robert Kennedy Jr. To say that we're going to wipe out mandates and everyone will have a choice, but this is a great step in the right direction." - "Half a billion dollars, 22 projects in the pipeline for mRNA vaccine technology." - "KFF Foundation did a survey on really what Americans are still going to want this vaccine going into the fall, the COVID vaccine."

Secretary Kennedy has achieved a significant victory, effectively silencing many critics. While not a ban on mRNA, the government, through BARDA, will cease investing in these technologies. Additionally, their global health investment corporation partner is advised to halt all equity investments in modified RNA technologies. The expectation is that without funding, these technologies will diminish. This development is considered a bombshell with worldwide repercussions.